Skip to main content
. 2019 Feb 14;126(5):1419–1429. doi: 10.1152/japplphysiol.01093.2018

Table 1.

Subject characteristics

Low Susceptibility High Susceptibility
Age, yr 52 (SD 23) (5/9) 53 (SD 23) (4/8)
Sample Size (male/female) 14 (8/6) 12 (5/7) ANOVA P Values
Height, cm 172 (SD 8) 175 (SD 5)
Pre Post Pre Post Bed Rest Low vs. High Interaction
Body mass, kg 74 (SD 14) 73 (SD 14) 71 (SD 9) 69 (SD 8) <0.001 0.435 0.263
BMI 25.03 (SD 3.8) 24.78 (SD 3.7) 23.04 (SD 2.2) 22.65 (SD 2.1) <0.001 0.103 0.337
Fat mass, kg 23 (SD 7) 23 (SD 7) 22 (SD 6) 22 (SD 5) 0.238 0.569 0.803
Whole body lean mass, kg 48 (SD 10) 47 (SD 9) 46 (SD 7) 45 (SD 6) <0.001 0.508 0.136
Insulin sensitivity (CLIX-IR) 5.51 (SD 2.0) 4.64 (SD 1.7) 7.02 (SD 2.7) 3.65 (SD 1.5) <0.001 0.729 <0.001
HOMA-IR 1.54 (SD 0.8) 1.50 (SD 0.8) 0.97 (SD 0.3) 1.18 (SD 0.6) 0.223 0.118 0.121
Matsuda Index 7.78 (SD 4.1) 7.59 (SD 6.0) 12.4 (SD 4.5)* 7.75 (SD 2.9) 0.002 0.166 0.003
Fasting glucose, mg/dl 92 (SD 6) 94 (SD 6) 91 (SD 10) 96 (SD 14) 0.020 0.895 0.309
Fasting insulin, µU/ml 6.68 (SD 3.2) 6.35 (SD 3.3) 3.99 (SD 1.9) 4.88 (SD 1.7) 0.435 0.046 0.091
120 min glucose, mg/dl 116 (SD 23) 122 (SD 35) 108 (SD 21) 134 (SD 55) 0.048 0.839 0.176
120 min insulin, µU/ml 58.4 (SD 70) 63.4 (SD 35) 21.7 (SD 19) 32.0 (SD 18) 0.041 0.120 0.468
AUC glucose, g·dl−1·min−1 15244 (SD 2185) 16154 (SD 2859) 14228 (SD 2827) 17493 (SD 4756) 0.001 0.889 0.048
AUC insulin, µU·ml−1·min−1 5914 (SD 4749) 6846 (SD 2859) 2749 (SD 934.9) 4896 (SD 1968) <0.001 0.089 0.049

Values are expressed as means (SD). BMI, body mass index; CLIX-IR, Clamp-Like Index; HOMA-IR, homeostatic model assessment of insulin resistance.

*

Different from Low Susceptibility with interaction (Sidak’s multiple-comparison test, P < 0.05).

Bed rest effect;

Group difference.